Efficacy and safety of enavogliflozin vs. dapagliflozin as add-on therapy in patients with type 2 diabetes mellitus based on renal function: a pooled analysis of two randomized controlled trials
Article in Cardiovascular Diabetology (February 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in Cardiovascular Diabetology (February 2024)
Preprint in Research Square (January 2024)
Article in Diabetes & Metabolic Syndrome Clinical Research & Reviews (July 2023)